magnetosbonegraft.com // cs@kurosbio.com
1
Duan R, et al. Eur Cell Mater 2019;37:60-73.
* In vitro or in vivo studies may not be predictive of clinical experience in humans.
†
MagnetOs is not cleared by FDA as an osteoinductive bone graft.
Kuros Biosciences B.V. or other corporate affi liated entities own, use or have applied for the following
trademarks or service marks: MagnetOs PROMO/MAG/US/003-20/R00 31 Mar 2020
The interplay between our skeletal and immune systems is the fi eld
of research known as osteoimmunology.
MagnetOs bone graft harnesses this interplay. Its unique submicron
surface topography polarizes macrophages to the pro-healing
M2 phenotype. These, in turn, upregulate mesenchymal stem cells,
leading to bone formation instead of scar tissue.
1*
Bone forms, even in soft tissue, without the need for added cells or
growth factors.
1*
†
are discovering how the power of osteoimmunology
can help eliminate non-unions
PIONEERING
SURGEONS
